Get started
Author

Amalia Carmona

Health-care costs of inflammatory bowel disease in a pan-European, community-based, inception cohort during 5 years of follow-up: a population-based study
2020 · Johan Burisch, Hillel Vardi, et al. · The Lancet. Gastroenterology & hepatology · 168
Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study
2021 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 105
Disease course of inflammatory bowel disease unclassified in a European population‐based inception cohort: An Epi‐IBD study
2018 · Johan Burisch, Stefania Chetcuti Zammit, et al. · Journal of Gastroenterology and Hepatology · 39
PDF
Complementary and alternative medicine in inflammatory bowel disease patients: Frequency and risk factors
2012 · Alberto Fernández, Manuel Barreiro-de Acosta, et al. · Digestive and Liver Disease · 38
Vitamin D deficiency in a European inflammatory bowel disease inception cohort: an Epi-IBD study
2018 · Stefania Chetcuti Zammit, Pierre Ellul, et al. · European Journal of Gastroenterology & Hepatology · 32
Occurrence of Anaemia in the First Year of Inflammatory Bowel Disease in a European Population-based Inception Cohort—An ECCO-EpiCom Study
2017 · Johan Burisch, Zsuzsanna Vegh, et al. · Journal of Crohn s and Colitis · 32
Reactantes de fase aguda y marcadores de inflamación en pacientes con enfermedad tromboembólica venosa: correlación con parámetros clínicos y evolutivos
2006 · P. J. Marchena Yglesias, J. A. Nieto Rodríguez, et al. · Anales de Medicina Interna · 31
PDF
Incidence and phenotype at diagnosis of inflammatory bowel disease. Results in Spain of the EpiCom study
2015 · Alberto Fernández, Vicent Hernández, et al. · Gastroenterología y Hepatología · 27
EpidemIBD: rationale and design of a large-scale epidemiological study of inflammatory bowel disease in Spain
2019 · María Chaparro, Manuel Barreiro-de Acosta, et al. · Therapeutic Advances in Gastroenterology · 24
Correction: Chaparro et al. Incidence, Clinical Characteristics and Management of Inflammatory Bowel Disease in Spain: Large-Scale Epidemiological Study. J. Clin. Med. 2021, 10, 2885
2022 · María Chaparro, Ana Garre, et al. · Journal of Clinical Medicine · 4
Incidence of inflammatory bowel disease and phenotype at diagnosis in 2011: results of Epi-IBD 2011 study in the Vigo area
2021 · Vicent Hernández, María Luisa de Castro, et al. · Revista Española de Enfermedades Digestivas · 2
Factores Predictores Del Uso De Tratamientos Biológicos O Pequeñas Moléculas, Cirugías Y Hospitalizaciones En Una Cohorte De Pacientes Recién Diagnosticados De Eii: Resultados a Largo Plazo Del Estudio Epidemibd De Geteccu
2025 · Ana Garre Vázquez, Andrea Núñez Ortiz, et al. · Gastroenterología y Hepatología · 1
P242 Complementary and alternative medicine in inflammatory bowel disease patients. Is it a real problem?
2012 · M. Barreiro-de Acosta, A. Fernandez, et al. · Journal of Crohn s and Colitis · 1
Clinical Course and Predictors of Biologic Therapy, Hospitalisation and Surgery: A Five‐Year Prospective Study in Newly Diagnosed Inflammatory Bowel Disease
2026 · Ana Garre, Andrea Nuñez Ortiz, et al. · Alimentary Pharmacology & Therapeutics
P665 Association of drugs and autoimmune diseases in patients diagnosed with microscopic colitis
2013 · J. Martínez Cadilla, P. Estevez Boullosa, et al. · Journal of Crohn s and Colitis
Works count: 15
Citation count: 504
H-index: 9
I10-index: 9
Year
Topic
Type